The criterion for selecting effective phage for Escherichia coli O157:H7 control

Biochemical Engineering Journal

Volumn 19, Issue 3, 2004, Pages 221-227

  Yoichi, Masatoshi ^a   Morita, Masatomo ^a   Mizoguchi, Katsunori ^a   Fischer, Curt R ^a   Unno, Hajime ^a   Tanji, Yasunori ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Bacteriophage; Escherichia coli O157:H7; Phage therapy; Phage resistant cells

Indexed keywords

BACTERIA; BACTERIOPHAGES; BIOCHEMICAL ENGINEERING; CELLS; SEWAGE SLUDGE; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

ACTIVATED SLUDGE; ANTIBACTERIAL POTENTIAL; PHAGE-RESISTANT CELLS;

ESCHERICHIA COLI;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM ISOLATION; COLONY FORMING UNIT; ESCHERICHIA COLI; FECES ANALYSIS; LIQUID; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIRULENCE; WASTE WATER;

ESCHERICHIA COLI; SUS SCROFA; UNIDENTIFIED BACTERIOPHAGE;

EID: 2542502635     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bej.2004.02.001     Document Type: Article

References (23)

1. Sulakvelidze A., Alavidze Z., Morris J.G. Jr. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:2001;649-659
2. Chopra I., Hodgson J., Metcalf B., Poste G. The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob. Agents Chemother. 41:1997;497-503
3. Silver L.L., Bostian K.A. Discovery and development of new antibiotics: the problem of antibiotic resistance. Antimicrob. Agents Chemother. 37:1993;377-383
4. Taylor P.W., Stapleton P.D., Luzio J.P. New ways to treat bacterial infections. Drug Discov. Today. 7:2002;1086-1091
5. Alisky J., Iczkowski K., Rapoport A., Troitsky N. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:1998;5-15
6. Barrow P.A. The use of bacteriophages for treatment and prevention of bacterial disease in animals and animal models of human infection. J. Chem. Technol. Biotechnol. 76:2001;677-682
7. Summers W.C. Bacteriophage therapy. Annu. Rev. Microbiol. 55:2001;437-451
8. Barrow P., Lovell M., Berchieri A. Jr. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diagn. Lab. Immunol. 5:1998;294-298
9. Biswas B., Adhya S., Washart P., Paul B., Trostel A.N., Powell B., Carlton R., Merril C.R. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:2002;204-210
10. Park S.C., Shimamura I., Fukunaga M., Mori K., Nakai T. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl. Environ. Microbiol. 66:2000;1416-1422
11. Smith H.W., Huggins M.B., Shaw K.M. The control of experimental Escherichia coli diarrhea in calves by means of bacteriophages. J. Gen. Microbiol. 133:1987;1111-1126
12. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:1998;142-201
13. Schroeder C.M., Zhao C., DebRoy C., Torcolini J., Zhao S., White D.G., Wagner D.D., McDermott P.F., Walker R.D., Meng J. Antimicrobial resistance of Escherichia coli O157 isolated from humans, cattle, swine, and food. Appl. Environ. Microbiol. 68:2002;576-581
14. Morita M., Tanji Y., Mizoguchi K., Akitsu T., Kijima N., Unno H. Characterization of a virulent bacteriophage specific for Escherichia coli O157:H7 and analysis of its cellular receptor and two tail fiber genes. FEMS Microbiol. Lett. 211:2002;77-83
15. Slauch J.M., Mahan M.J., Michetti P., Neutra M.R., Mekalanos J.J. Acetylation (O-Factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen. Infect. Immun. 63:1995;437-441
16. Fujimoto S., Meno Y., Horikawa K. Heterogeneity in expression of lipopolysaccharide and major outer-membrane proteins by strains of Escherichia coli O157 with different H-serotypes. Microbiol. Immunol. 42:1998;527-531
17. J. Sambrook, D.W. Russell, Molecular Cloning. A Laboratory Manual, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001.
18. C.J. Hurst, An introduction to viral taxonomy and the proposal of akamara, a potential domain for the genomic acellular agents, in: C.J. Hurst (Ed.), Viral Ecology, Academic Press, San Diego, CA, 2000, pp. 41-62.
19. Kudva I.T., Jelacic S., Tarr P.I., Youderian P., Hovde C.J. Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl. Environ. Microbiol. 65:1999;3767-3773
20. Ronner A.B., Cliver D.O. Isolation and characterization of a coliphage specific for Escherichia coli O157:H7. J. Food Prot. 53:1990;944-947
21. Carlson N.G., Little J.W. A novel antivirulence element in the temperate bacteriophage HK022. J. Bacteriol. 175:1993;7541-7549
22. K. Carlson, E.A. Raleigh, S. Hattman, Restriction and modification, in: J.D. Karam (Ed.), Bacteriophage T4, ASM Press, Washington, DC, 1994, pp. 369-381.
23. Mizoguchi K., Morita M., Fischer C.R., Yoichi M., Tanji Y., Unno H. Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl. Environ. Microbiol. 69:2003;170-176